Related Experiment Videos
Computer-aided target selection-prioritizing targets for antifungal drug discovery
Spaltmann1, Blunck, Ziegelbauer
1Institute for Antiinfective Research, Bayer AG, D-42096 Wuppertal, Germany.
Drug Discovery Today
|May 11, 1999
Summary
Researchers developed a software tool to identify antifungal drug targets by analyzing the Saccharomyces cerevisiae genome. This computational approach aids in selecting the most promising genes for antimycotic drug discovery.
Area of Science:
- Genomics
- Computational Biology
- Drug Discovery
Background:
- The completion of the Saccharomyces cerevisiae genome provided a molecular blueprint for eukaryotic organisms.
- Human pathogenic fungi like Candida albicans share genetic similarities with S. cerevisiae.
- Identifying novel antifungal drug targets is crucial for combating fungal infections.
Purpose of the Study:
- To develop a method for identifying and prioritizing S. cerevisiae genes as potential antifungal drug targets.
- To leverage genomic information for advancing antimycotic drug discovery.
Main Methods:
- Development of a software tool named CATS (computer-aided target selection).
- Automated assessment of S. cerevisiae genes for their suitability as antifungal targets.
- Periodic updates to the gene suitability assessment.
Main Results:
- CATS enables systematic evaluation of all S. cerevisiae genes.
- The tool facilitates the prioritization of genes for drug development.
- Provides a dynamic resource for antifungal target identification.
Conclusions:
- The CATS software is a valuable tool for antifungal drug discovery research.
- Utilizing genomic data through computational tools accelerates the identification of therapeutic targets.
- This approach aids in the molecular understanding and treatment of fungal diseases.